William J Gradishar (William Gradishar)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Circulating Tumor

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Qiang Zhang, Zheng Cai, Lorenzo Gerratana, Andrew A Davis, Paolo D'Amico, Akhil Chawla, Saya L Jacob, Youbin Zhang, Jianhua Jiao, Weijun Qin, Giancarlo Feliciello, Lisa Flaum, Ami N Shah, William J Gradishar
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Chiara Corti, Hemali Batra-Sharma, Max Kelsten, Rebecca A Shatsky, Ana C Garrido-Castro, William J Gradishar
Systemic Therapy in Breast Cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Qiang Zhang, Zheng Cai, Lorenzo Gerratana, Andrew A Davis, Paolo D'Amico, Akhil Chawla, Saya L Jacob, Youbin Zhang, Jianhua Jiao, Weijun Qin, Giancarlo Feliciello, Lisa Flaum, Ami N Shah, William J Gradishar
Early evaluation of risk stratification and clinical outcomes for patients with advanced breast cancer through combined monitoring of baseline circulating tumor cells and DNA. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kevin M Kalinsky, Melissa K Accordino, Codruta Chiuzan, Prabhjot S Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea N Baer, Sun Y Oh, Amelia B Zelnak, Kari B Wisinski, Eleni Andreopoulou, William J Gradishar, Erica M Stringer-Reasor, Sonya A Reid, Anne O'Dea, Ruth M O'Regan, Katherine D Crew, Dawn L Hershman
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
William J Gradishar, Ruth M O'Regan, Mothaffar F Rimawi, Jeffrey L Nordstrom, Minori K Rosales, Hope S Rugo
Margetuximab in HER2-positive metastatic breast cancer. Future oncology (London, England) (2023)
Raoul Charles Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi I Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William J Gradishar, Sagar Sardesai, Jason Melear, Joyce O'Shaughnessy, Patrick J Ward, Pavani Chalasani, Tobias Arkenau, Richard D Baird, Rinath M Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew G Krebs
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications 14 (1) (2023)
Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, Giancarlo Feliciello, Katherine K Clifton, Leslie A Bucheit, Whitney L Hensing, Ami N Shah, Tania Pivetta, Charles S Dai, Paolo D'Amico, Firas H Wehbe, Arielle J Medford, Seth A Wander, William J Gradishar, Amir Behdad, Cynthia X Ma, Fabio Puglisi, Aditya Bardia, Massimo Cristofanilli
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. JCO precision oncology 7 (2023)
Raoul Charles Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi I Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William J Gradishar, Sagar Sardesai, Jason Melear, Joyce O'Shaughnessy, Patrick J Ward, Pavani Chalasani, Tobias Arkenau, Richard D Baird, Rinath M Jeselsohn, Simak Ali, Glen Clack, Ashwani Bahl, Stuart McIntosh, Matthew G Krebs
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications 14 (1) (2023)
Nurmaa K Dashzeveg, Yuzhi Jia, Youbin Zhang, Lorenzo Gerratana, Priyam A Patel, Asif Shajahan, Tsogbadrakh Dandar, Erika K Ramos, Hannah F Almubarak, Valery Adorno-Cruz, Rokana Taftaf, Emma J Schuster, David Scholten, Michael T Sokolowski, Giancarlo Feliciello, Lamiaa El-Shennawy, Andrew D Hoffmann, Maroua Manai, Qiang Zhang, Paolo D'Amico, Parastoo Azadi, Karen J Colley, Leonidas C Platanias, Ami N Shah, William J Gradishar, Massimo Cristofanilli, William A Muller, Brian A Cobb, Huiping Liu
Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer. Cancer discovery (2023)
Elena Shagisultanova, William J Gradishar, Ursa Brown-Glabberman, Pavani Chalasani, Andrew J Brenner, Alison T Stopeck, Hannah Parris, Dexiang Gao, Tessa Mcspadden, Jose Mayordomo, Jennifer R Diamond, Peter Kabos, Virginia F Borges
Safety and efficacy of tucatinib, letrozole and palbociclib in patients with previously treated HR+/HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, Giancarlo Feliciello, Katherine K Clifton, Leslie A Bucheit, Whitney L Hensing, Ami N Shah, Tania Pivetta, Charles S Dai, Paolo D'Amico, Firas H Wehbe, Arielle J Medford, Seth A Wander, William J Gradishar, Amir Behdad, Cynthia X Ma, Fabio Puglisi, Aditya Bardia, Massimo Cristofanilli
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. JCO precision oncology 7 (2023)
Hope S Rugo, Seock-Ah Im, Fatima Cardoso, Javier Cortes, Giuseppe Curigliano, Antonino Musolino, Mark D Pegram, Thomas Bachelot, Gail S Wright, Cristina Saura, Santiago Escrivá-de-Romaní, Michelino De Laurentiis, Gary N Schwartz, Timothy J Pluard, Francesco Ricci, William R Gwin, Christelle Levy, Ursa Brown-Glaberman, Jean-Marc Ferrero, Maaike de Boer, Sung-Bae Kim, Katarína Petráková, Denise A Yardley, Orit Freedman, Erik H Jakobsen, Einav Nili Gal-Yam, Rinat Yerushalmi, Peter Andreas Fasching, Peter A Kaufman, Emily J Ashley, Raul Perez-Olle, Shengyan Hong, Minori Koshiji Rosales, William J Gradishar, null null
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Lorenzo Gerratana, Michael Movarek, Firas H Wehbe, Neelima Katam, Devalingam Mahalingam, Jeannine Donahue, Ami Shah, Young Kwang Chae, Mary F Mulcahy, Dean Tsarwhas, Victoria Villaflor, Aparna Kalyan, Maha H A Hussain, Jyoti D Patel, Sunandana Chandra, Leonidas C Platanias, William J Gradishar, Massimo Cristofanilli, Amir Behdad
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 6 (2022)
Stephen R D Johnston, William J Gradishar
Reply to S. Sorscher. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Siobhan M Phillips, Payton Solk, Whitney A Welch, Lisa A Auster-Gussman, Marilyn Lu, Erin Cullather, Emily Torre, Madelyn Whitaker, Emily Izenman, Jennifer La, Jungwha Lee, Bonnie J Spring, William J Gradishar
A Technology-Based Physical Activity Intervention for Patients With Metastatic Breast Cancer (Fit2ThriveMB): Protocol for a Randomized Controlled Trial. JMIR research protocols 10 (4) (2021)
Julia R Trosman, Christine B Weldon, Bruce D Rapkin, Al B Benson, Della F Makower, Su-Ying Liang, Swati A Kulkarni, Claudia B Perez, Shelly S Lo, Editha A Krueger, Alyssa D Throckmorton, Christopher M Gallagher, Kent F Hoskins, Cathleen M Schaeffer, Jennifer Van Horn, Lidia Schapira, Arliene Ravelo, Elaine Yu, William J Gradishar
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers. JCO oncology practice 17 (8) (2021)